David E. Leaf

14.0k total citations · 3 hit papers
111 papers, 4.9k citations indexed

About

David E. Leaf is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David E. Leaf has authored 111 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Nephrology, 24 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in David E. Leaf's work include Acute Kidney Injury Research (20 papers), Parathyroid Disorders and Treatments (15 papers) and COVID-19 Clinical Research Studies (14 papers). David E. Leaf is often cited by papers focused on Acute Kidney Injury Research (20 papers), Parathyroid Disorders and Treatments (15 papers) and COVID-19 Clinical Research Studies (14 papers). David E. Leaf collaborates with scholars based in United States, Netherlands and Canada. David E. Leaf's co-authors include David S. Goldfarb, Sushrut S. Waikar, Miguel A. Hernán, Wei Wang, Shruti Gupta, Marta Christov, Hanny Al‐Samkari, Pavan K. Bendapudi, Katayoon Goodarzi and Sunny Dzik and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

David E. Leaf

103 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

2020 855 citations Hanny Al‐Samkari, Shruti Gupta et al. profile →
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors

2016 452 citations David E. Leaf et al. Kidney International profile →
Target Trial Emulation

2022 378 citations Miguel A. Hernán, Wei Wang et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Leaf United States	36	1.3k	1.2k	985	938	531	111	4.9k
Emad Kandil United States	40	627 0.5×	1.0k 0.9×	489 0.5×	683 0.7×	739 1.4×	371	6.9k
Stuart D. Katz United States	48	546 0.4×	261 0.2×	686 0.7×	955 1.0×	828 1.6×	230	9.4k
Timothy S. Larson United States	47	2.7k 2.1×	874 0.8×	252 0.3×	1.4k 1.5×	557 1.0×	105	7.7k
Feng Lin United States	45	1.2k 0.9×	346 0.3×	252 0.3×	585 0.6×	384 0.7×	173	7.1k
Julio Núñez Spain	45	652 0.5×	917 0.8×	312 0.3×	1.4k 1.5×	794 1.5×	560	10.0k
Andrzej Więcek Poland	38	1.9k 1.5×	547 0.5×	251 0.3×	1.0k 1.1×	1000 1.9×	482	7.6k
Carlo Lombardi Italy	36	431 0.3×	355 0.3×	1.2k 1.3×	1.3k 1.3×	506 1.0×	216	5.9k
Maarten Naesens Belgium	55	2.1k 1.6×	972 0.8×	595 0.6×	1.3k 1.4×	1.1k 2.1×	242	9.0k
Patompong Ungprasert United States	46	765 0.6×	388 0.3×	214 0.2×	1.9k 2.0×	743 1.4×	309	7.1k
F. Perry Wilson United States	40	2.2k 1.7×	333 0.3×	345 0.4×	1.6k 1.7×	514 1.0×	181	5.8k

Countries citing papers authored by David E. Leaf

Since Specialization

Citations

This map shows the geographic impact of David E. Leaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Leaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Leaf more than expected).

Fields of papers citing papers by David E. Leaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Leaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Leaf. The network helps show where David E. Leaf may publish in the future.

Co-authorship network of co-authors of David E. Leaf

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Leaf. A scholar is included among the top collaborators of David E. Leaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Leaf. David E. Leaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leaf, David E., Shruti Gupta, Adit A. Ginde, et al.. (2025). Randomized trial of activated vitamin D for acute kidney injury prevention in critically ill patients. JCI Insight. 10(20).

Herrmann, Sandra M., Ala Abudayyeh, Shruti Gupta, et al.. (2024). Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrology. Kidney International. 107(1). 21–32. 12 indexed citations

Leaf, Rebecca Karp, Hetanshi Naik, Sarina B. Elmariah, et al.. (2024). Afamelanotide for Treatment of the Protoporphyrias: Impact on Quality of Life and Laboratory Parameters in a US Cohort. Life. 14(6). 689–689. 2 indexed citations

Lux, François, Laurent David, A. Couturier, et al.. (2023). Iron as an emerging therapeutic target in critically ill patients. Critical Care. 27(1). 475–475. 9 indexed citations

Johnson, P. Connor, Haesook T. Kim, Meghan E. Sise, et al.. (2023). Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(7). 455.e1–455.e9. 3 indexed citations

Short, Samuel, Charlotte Thomas, Dylan J. Martini, et al.. (2023). AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplantation. 59(2). 178–188. 3 indexed citations

Green, Adam, Jean-Sébastien Rachoin, Christa Schorr, et al.. (2023). Timing of invasive mechanical ventilation and death in critically ill adults with COVID-19: A multicenter cohort study. PLoS ONE. 18(6). e0285748–e0285748. 3 indexed citations

Murakami, Naoka, Thomas Hills, Hanny Al‐Samkari, et al.. (2022). Therapeutic advances in COVID-19. Nature Reviews Nephrology. 19(1). 38–52. 92 indexed citations

Hernán, Miguel A., Wei Wang, & David E. Leaf. (2022). Target Trial Emulation. JAMA. 328(24). 2446–2446. 378 indexed citations breakdown →

10.

Ricardo, Ana C., Jinsong Chen, Stephanie M. Toth‐Manikowski, et al.. (2022). Hispanic ethnicity and mortality among critically ill patients with COVID-19. PLoS ONE. 17(5). e0268022–e0268022. 14 indexed citations

11.

Vasbinder, Alexi, Chelsea Meloche, Tariq U. Azam, et al.. (2022). Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19. Circulation Cardiovascular Quality and Outcomes. 15(10). e008942–e008942. 20 indexed citations

12.

Kelly, Yvelynne P., Kavita Mistry, Salman Ahmed, et al.. (2021). Controlled Study of Decision-Making Algorithms for Kidney Replacement Therapy Initiation in Acute Kidney Injury. Clinical Journal of the American Society of Nephrology. 17(2). 194–204. 2 indexed citations

13.

Churpek, Matthew M., Shruti Gupta, Alexandra B. Spicer, et al.. (2021). Hospital-Level Variation in Death for Critically Ill Patients with COVID-19. American Journal of Respiratory and Critical Care Medicine. 204(4). 403–411. 30 indexed citations

14.

Gupta, Shruti, Harish Seethapathy, Ian A. Strohbehn, et al.. (2020). Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma. American Journal of Kidney Diseases. 76(1). 63–71. 80 indexed citations

15.

Molnar, Miklos Z., Anshul Bhalla, Makoto Tsujita, et al.. (2020). Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States. American Journal of Transplantation. 20(11). 3061–3071. 71 indexed citations

16.

Lee, Meghan, Ian A. Strohbehn, Harish Seethapathy, et al.. (2020). Clinical Features of AKI in Patients Receiving Tisagenlecleucel (CAR-T Therapy). Journal of the American Society of Nephrology. 31(10S). 664–664.

17.

Eisenga, Michele F., Maarten A. de Jong, David E. Leaf, et al.. (2020). Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation. Journal of Clinical Medicine. 9(6). 1737–1737.

18.

Leaf, David E. & Sushrut S. Waikar. (2019). IDEAL-ICU in Context. Clinical Journal of the American Society of Nephrology. 14(8). 1264–1267. 5 indexed citations

19.

Zhao, Bixiao, Qiongshi Lu, Yu‐Wei Cheng, et al.. (2016). A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury. American Journal of Respiratory and Critical Care Medicine. 195(4). 482–490. 29 indexed citations

20.

Leaf, David E., Anas Raed, Michael W. Donnino, Adit A. Ginde, & Sushrut S. Waikar. (2014). Randomized Controlled Trial of Calcitriol in Severe Sepsis. American Journal of Respiratory and Critical Care Medicine. 190(5). 533–541. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact